Literature DB >> 30305453

GDP-l-fucose synthase is a CD4+ T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis.

Raquel Planas1, Radleigh Santos2, Paula Tomas-Ojer1, Carolina Cruciani1, Andreas Lutterotti1, Wolfgang Faigle1, Nicole Schaeren-Wiemers3, Carmen Espejo4, Herena Eixarch4, Clemencia Pinilla2, Roland Martin1, Mireia Sospedra5.   

Abstract

Multiple sclerosis is an immune-mediated autoimmune disease of the central nervous system that develops in genetically susceptible individuals and likely requires environmental triggers. The autoantigens and molecular mimics triggering the autoimmune response in multiple sclerosis remain incompletely understood. By using a brain-infiltrating CD4+ T cell clone that is clonally expanded in multiple sclerosis brain lesions and a systematic approach for the identification of its target antigens, positional scanning peptide libraries in combination with biometrical analysis, we have identified guanosine diphosphate (GDP)-l-fucose synthase as an autoantigen that is recognized by cerebrospinal fluid-infiltrating CD4+ T cells from HLA-DRB3*-positive patients. Significant associations were found between reactivity to GDP-l-fucose synthase peptides and DRB3*02:02 expression, along with reactivity against an immunodominant myelin basic protein peptide. These results, coupled with the cross-recognition of homologous peptides from gut microbiota, suggest a possible role of this antigen as an inducer or driver of pathogenic autoimmune responses in multiple sclerosis.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30305453     DOI: 10.1126/scitranslmed.aat4301

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  33 in total

1.  The immune signatures of multiple sclerosis: Lessons from twin studies.

Authors:  Pablo Villoslada; Scott S Zamvil
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-14       Impact factor: 11.205

Review 2.  Host-microbiota interactions in immune-mediated diseases.

Authors:  William E Ruff; Teri M Greiling; Martin A Kriegel
Journal:  Nat Rev Microbiol       Date:  2020-05-26       Impact factor: 60.633

Review 3.  Ro60 and Y RNAs: structure, functions, and roles in autoimmunity.

Authors:  Marco Boccitto; Sandra L Wolin
Journal:  Crit Rev Biochem Mol Biol       Date:  2019-05-14       Impact factor: 8.250

4.  Gut Microbiota as a Potential Predictive Biomarker in Relapsing-Remitting Multiple Sclerosis.

Authors:  Vicente Navarro-López; María Ángeles Méndez-Miralles; Rosa Vela-Yebra; Ana Fríes-Ramos; Pedro Sánchez-Pellicer; Beatriz Ruzafa-Costas; Eva Núñez-Delegido; Humberto Gómez-Gómez; Sara Chumillas-Lidón; Jose A Picó-Monllor; Laura Navarro-Moratalla
Journal:  Genes (Basel)       Date:  2022-05-23       Impact factor: 4.141

5.  Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.

Authors:  Mark N Lee; Matthew Meyerson
Journal:  Sci Immunol       Date:  2021-01-22

Review 6.  The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.

Authors:  Caterina Veroni; Francesca Aloisi
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

Review 7.  Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases.

Authors:  Heinz Wiendl; Catharina C Gross; Jan Bauer; Doron Merkler; Alexandre Prat; Roland Liblau
Journal:  Nat Rev Neurol       Date:  2021-05-28       Impact factor: 42.937

Review 8.  Influence of immunomodulatory drugs on the gut microbiota.

Authors:  Inessa Cohen; William E Ruff; Erin E Longbrake
Journal:  Transl Res       Date:  2021-01-27       Impact factor: 10.171

9.  Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis.

Authors:  Mattias Bronge; Klara Asplund Högelin; Olivia G Thomas; Sabrina Ruhrmann; Claudia Carvalho-Queiroz; Ola B Nilsson; Andreas Kaiser; Manuel Zeitelhofer; Erik Holmgren; Mathias Linnerbauer; Milena Z Adzemovic; Cecilia Hellström; Ivan Jelcic; Hao Liu; Peter Nilsson; Jan Hillert; Lou Brundin; Katharina Fink; Ingrid Kockum; Katarina Tengvall; Roland Martin; Hanna Tegel; Torbjörn Gräslund; Faiez Al Nimer; André Ortlieb Guerreiro-Cacais; Mohsen Khademi; Guro Gafvelin; Tomas Olsson; Hans Grönlund
Journal:  Sci Adv       Date:  2022-04-27       Impact factor: 14.957

Review 10.  Sepsis and multiple sclerosis: Causative links and outcomes.

Authors:  Đorđe Miljković; Suzana Stanisavljević; Isaac J Jensen; Thomas S Griffith; Vladimir P Badovinac
Journal:  Immunol Lett       Date:  2021-07-25       Impact factor: 4.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.